Sprunglinks
  • Zur Hauptnavigation
  • Zum Inhalt
  • Zur Suche
  • Contact
  • FAQs
  • News-Event-Blog
Contact us now: triceps@dualsystems.com / +41 44 738 50 00
Dualsystems Biotech AG
  • Link to LinkedIn
  • Link to Youtube
Hauptnavigation
  • Pretest
    • Pretest TriCEPS Service and Kit
    • Flow-TriCEPS
    • TAMRA-TriCEPS
  • LRC-TriCEPS
    • LRC-TriCEPS
    • FAQs
    • Testimonials
    • Example Report using primary human T-cells
    • Affinity and receptor expression
    • Cell types – cell lines used with LRC-TriCEPS
    • Technologies for targeting the cell surfaceome
    • LRC-TriCEPS Video
    • LRC-TriCEPS customers worldwide
    • Manual
  • Target confirmation
  • Cell Surface Protein identification
  • Publications
  • Company
    • Company
    • Management of Dualsystems
    • Scientific Board
    • Career Opportunities
    • Our partners
    • Investors
    • Tools
    • Terms & Conditions
    • Terms of use agreement
  • Contact
  • News
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Archives

You are here: Home1 / 2 / Publications
Antimicrobial Peptides Derived from the Immune, Defense Protein CAP37 Inhibit TLR4 Activation by S100A9

April 16, 2020

Acidity changes immunology: a new VISTA pathway

January 21, 2020

Nature Article VISTA interaction with PSGL-1 identified by LRC-TriCEPS

October 23, 2019

Anti-VISTA antibody that inhibits Vista function and blocks interaction with PSGL-1 and VSIG3 proteins slows tumor growth

October 14, 2019

Phage resistance at the cost of virulence

October 07, 2019

White Paper Ligand-Receptor Identification Methodologies Details Matter

April 02, 2019

Validation of extracellular ligand–receptor interactions by Flow‑TriCEPS

December 05, 2018

Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution, Imaging Application, and Mechanism of Transduction

November 14, 2018

Leukocyte differentiation by histidine-rich glycoprotein/stanniocalcin-2 complex regulates murine glioma growth through modulation of anti-tumor immunity

June 19, 2018

Protter

November 21, 2013

Footer

Dualsystems Biotech AG

Dr. Paul Helbling
Grabenstrasse 11a
8952 Schlieren
Switzerland
phone +41 44 738 50 00
fax +41 44 738 50 05

LRC-TriCEPS Video

LRC-TriCEPS explained in a short video

Social Media

Sharebutton linkedin
Sharebutton youtube

© Copyright - Dualsystems Biotech AG | Realization by web updates kmu GmbH | Impressum | Terms & Conditions | Privacy Policy
Scroll to top Scroll to top Scroll to top
DO YOU WANT TO TEST IT NOW?
Transport not incl. Your Information will never be shared with any third party.
To get pretest TriCEPS Material please contact us!

Identify the targets of your ligand on the living cells. Prior to the main experiment get free TriCEPS Material to test the functionality of your TriCEPS coupled ligand.
  • Extracellular proteins
  • Peptide ligands
  • Antibodies
  • Engineered affinity binders
  • Viruses
YES!
×
DO YOU WANT TO TALK TO US?
Your information will never be shared with any third party.
LRC-TriCEPS to identify targets on the surface of living cells.

Please provide your email address and we will contact you to arrange a call.
  • Small molecules
  • Extracellular proteins
  • Peptide ligands
  • Antibodies
  • Engineered affinity binders
  • Viruses
YES!
×